Isolated Central Nervous System Blast Crisis of Chronic Myeloid Leukemia with Dasatinib Therapy.

BACKGROUND

Isolated central nervous system (CNS) blast crisis was uncommon in chronic myeloid leukemia (CML).

METHODS

The present study reported an interesting case of a CML patient administered with dasatinib presenting with headache and seizure unconsciousness. Imaging investigation, immunophenotyping, bone marrow cytology inspection, chromosomal analysis, and polymerase chain reaction (PCR) were performed on a 41-year-old CML patient.

RESULTS

Bone marrow examination revealed complete cytogenetic remission and there were no obvious abnormalities in head CT and MR. Cytomorphological examination of cerebrospinal fluid (CSF) showed 50% blasts. Flow cytometry analysis was showed 78.3% CSF cells expressing the specific myeloid antigens. PCR analysis on CSF cells was positive for BCR/ABL P210 fusion gene. All the above CSF findings were suggestive of CNS infiltrating isolated from bone marrow cytogenetic remission.

CONCLUSIONS

Isolated CNS blast crisis of CML with dasatinib were rare. The mechanism still remains unclear and the treatment regimen requires further exploration. Flow cytometry showed great value to detect the blast cells in this patient.